Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ ECMatrix™-411 E8 Laminin Subtrate

Catalog No. CC162350UMI Shop All MilliporeSigma Products
Change view
Click to view available options
Packaging:
2 x 175 μg
6 x 175 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Packaging
CC162350UMI 2 x 175 μg
CC1621050MI 6 x 175 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. CC162350UMI Supplier MilliporeSigma™ Supplier No. CC162350UG
Only null left
Add to Cart
Add to Cart

ECMatrix™-411 E8 Laminin Subtrate Xeno-free laminin-411 coating for the differentiation of pluripotent stem cells into endothelial cells

  • Endothelial cells line the interior surface of blood and lymphatic vessels, forming an interface between circulating blood or lymph in the lumen and the rest of tissue/organ
  • Laminin-411 binds to the integrin α6β1, located on the cell surface of pluripotent stem cells and induces endothelial cell differentiation
TRUSTED_SUSTAINABILITY

Specifications

Cell Type Pluripotent stem cells into endothelial cells
Content And Storage 2° to 8°C, Avoid multiple freeze-thaw cycles and protect from light
Form Liquid
Substrate Laminin substrate
Includes 2 x 175 μg ECMatrix™-411 E8 Laminin Substrate (expressed in CHO-S cells)
Packaging 2 x 175 μg
Storage Requirements 2° to 8°C, Avoid multiple freeze-thaw cycles and protect them from light
Substrate Quantity 0.5 mg/mL in PBS

For research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.